[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562398":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":27,"responsibleParty":45,"collaborators":48,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":10,"maxAge":73,"enrollmentInfo":74,"targetDuration":10,"studyType":77,"phases":10,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":91,"completionDateStruct":93,"leadSponsor":95,"locationsCount":96},{"fullName":5,"class":6},"University of Florence","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"CAYA Melanoma patients",null,"Patients under 30 years of age at the moment of melanoma diagnosis. The patients have been divided in Children (1-14 yrs), Adolescents (15-18 yrs) and Young Adults (18-30 yrs) based on the age of diagnosis.",[13],{"name":14,"affiliation":15,"role":16},"Massi Daniela","University of Florence (UNIFI)","PRINCIPAL_INVESTIGATOR",[18,24],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},"Daniela Massi Professor","CONTACT","3925536585","+39","daniela.massi@unifi.it",{"name":25,"role":20,"phone":21,"phoneExt":22,"email":26},"Dario Di Gangi Doctor","dario.digangi@unifi.it",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":31,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Florence","Italy","50139","IT",{"type":35,"coordinates":36},"Point",[37,38],11.24626,43.77925,{"lat":38,"lon":37},[41,43,44],{"name":19,"role":20,"phone":42,"phoneExt":22,"email":23},"05579490982",{"name":25,"role":20,"phone":21,"phoneExt":22,"email":26},{"name":19,"role":20,"phone":10,"phoneExt":10,"email":10},{"type":16,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Daniela Massi","Professor",[49,52,54,56,58,60,62],{"name":50,"class":51},"Tubingen University Hospital","UNKNOWN",{"name":53,"class":6},"Maria Sklodowska-Curie National Research Institute of Oncology",{"name":55,"class":51},"Fondazione IRCCS ISTITUTO NAZIONALE TUMORI",{"name":57,"class":6},"Hospital Clinic of Barcelona",{"name":59,"class":6},"Istanbul University",{"name":61,"class":6},"University Of Perugia",{"name":63,"class":6},"German Cancer Research Center","100562398","melcaya---novel-health-care-strategies-for-melanoma-in-children-adolescents-and-young-adults---work-package-3-wp3-100562398",false,"NCT06602648","MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3)","Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults. Histological, Computational, and Molecular Pathology for Improved Diagnosis. (Mol-Mel). Work Package 3 (WP3)","Mol-Mel","Inclusion Criteria:\n\n* adolescent and childhood patients (\\< 20 years) or young adults (\\< 30 years)\n* histologically confirmed diagnosis of melanoma or intermediate\u002Fambiguous melanocytic neoplasm (i.e., melanocytomas, SAMPUS, IAMPUS and MELTUMP according to WHO classification)\n\nExclusion criteria:\n\n* adult patients (\\> 30 years of age)\n* patients without histologically confirmed diagnosis of melanoma or intermediate\u002Fambiguous melanocytic neoplasm","ALL","30 Years",{"count":75,"type":76},100,"ESTIMATED","OBSERVATIONAL","The aim of this study is to investigate a type of skin cancer, also known as melanoma, in children, adolescents, and young adults, who will be referred to as CAYA patients in this project. The need for this study arises because this disease, in CAYA patients, is still poorly understood due to its rarity in individuals under 30 years old. This often leads to difficulties in assessing its severity and, consequently, in deciding on the necessary treatments to ensure the patient\\'s recovery. The goal of this study is to examine melanoma in CAYA patients in order to gather the information needed to provide better diagnoses for affected patients and, as a result, select appropriate treatments to fight the disease and promote the patient\\'s full recovery. Additionally, the data collected will be used to create a Pan-European online platform that will allow doctors across the European Union to consult the obtained data and collaborate on particularly complex melanoma cases, always with the aim of ensuring the patient\\'s full recovery in the shortest possible time.",[80],"Melanoma of Skin",[82,83,84,85,86],"Melanoma","Pediatric","Childrens","Adolescents","Young adults","2024-09-17",{"date":89,"type":90},"2024-09-19","ACTUAL",{"date":92,"type":90},"2024-04-17",{"date":94,"type":76},"2026-11",{"name":5,"class":6},1]